N-piperidin-4-yl-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide

C16H25N3O4S — CID 119387593

IUPACN-piperidin-4-yl-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide
SMILESCC(C)Oc1ccc(NS(=O)(=O)CC(=O)NC2CCNCC2)cc1
InChIInChI=1S/C16H25N3O4S/c1-12(2)23-15-5-3-14(4-6-15)19-24(21,22)11-16(20)18-13-7-9-17-10-8-13/h3-6,12-13,17,19H,7-11H2,1-2H3,(H,18,20)
InChIKeyDJKNTIGTOHAOEC-UHFFFAOYSA-N
MW355.46 g/mol
LogP1.08
Rot. Bonds7

About N-piperidin-4-yl-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide

N-piperidin-4-yl-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide (PubChem CID 119387593) has the molecular formula C16H25N3O4S and a molecular weight of 355.46 g/mol. Its IUPAC name is N-piperidin-4-yl-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide.

Molecular Properties

Compound NameN-piperidin-4-yl-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide
PubChem CID119387593
Molecular FormulaC16H25N3O4S
Molecular Weight355.46 g/mol
Exact Mass355.16
IUPAC NameN-piperidin-4-yl-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide
SMILESCC(C)Oc1ccc(NS(=O)(=O)CC(=O)NC2CCNCC2)cc1
InChIInChI=1S/C16H25N3O4S/c1-12(2)23-15-5-3-14(4-6-15)19-24(21,22)11-16(20)18-13-7-9-17-10-8-13/h3-6,12-13,17,19H,7-11H2,1-2H3,(H,18,20)
InChIKeyDJKNTIGTOHAOEC-UHFFFAOYSA-N
XLogP1.08
TPSA96.53 Ų
H-Bond Donors3
H-Bond Acceptors5
Rotatable Bonds7
Heavy Atoms24
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500355.46
LogP ≤ 51.08
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 105

Analyze N-piperidin-4-yl-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[(4-propan-2-yloxyphenyl)sulfamoyl]-N-pyrrolidin-3-ylacetamide;hydrochloride
CID 119451342
cis-(1R,3S)-3-[[2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetyl]amino]cyclopentane-1-carboxylic acid
CID 120677637
2-oxo-2-piperazin-1-yl-N-(4-propan-2-yloxyphenyl)ethanesulfonamide
CID 119401538
N-(2-piperazin-1-ylethyl)-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide;hydrochloride
CID 119446567
N-(2-piperidin-3-ylethyl)-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide
CID 119556769
2-[(4-propan-2-yloxyphenyl)sulfamoyl]-N-propyl-N-pyrrolidin-3-ylacetamide
CID 119531108
N-(4-methylphenyl)-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide
CID 55826239
3-methyl-2-[[2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetyl]amino]pentanoic acid
CID 119212048
N-cyclopentyl-N'-(4-propan-2-yloxyphenyl)propanediamide
CID 108942248
2-[propan-2-yl-[2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetyl]amino]acetic acid
CID 119198613
2-methyl-N-[1-[2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetyl]piperidin-4-yl]benzamide
CID 55962836
N-cyclohexyl-N'-(4-propan-2-yloxyphenyl)propanediamide
CID 108942623

Frequently Asked Questions

What is the IUPAC name of N-piperidin-4-yl-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide?
The IUPAC name of N-piperidin-4-yl-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide (CID 119387593) is N-piperidin-4-yl-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide.
What is the SMILES notation for N-piperidin-4-yl-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide?
The canonical SMILES for N-piperidin-4-yl-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide is CC(C)Oc1ccc(NS(=O)(=O)CC(=O)NC2CCNCC2)cc1.
What is the InChIKey of N-piperidin-4-yl-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide?
The InChIKey is DJKNTIGTOHAOEC-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H25N3O4S/c1-12(2)23-15-5-3-14(4-6-15)19-24(21,22)11-16(20)18-13-7-9-17-10-8-13/h3-6,12-13,17,19H,7-11H2,1-2H3,(H,18,20).
What are the key properties of N-piperidin-4-yl-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide?
N-piperidin-4-yl-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide has a molecular weight of 355.46 g/mol, XLogP of 1.08, 7 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-piperidin-4-yl-2-[(4-propan-2-yloxyphenyl)sulfamoyl]acetamide is sourced from PubChem (CID 119387593), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).